Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,434
  • Shares Outstanding, K 23,872
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,200 K
  • 60-Month Beta 1.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.79
Trade HOTH with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3600 +13.24%
on 05/19/21
2.2000 -30.00%
on 06/07/21
+0.1000 (+6.94%)
since 05/18/21
3-Month
1.2663 +21.61%
on 05/11/21
3.1500 -51.11%
on 03/23/21
-0.6200 (-28.70%)
since 03/18/21
52-Week
1.2663 +21.61%
on 05/11/21
3.8900 -60.41%
on 07/17/20
-1.1000 (-41.67%)
since 06/18/20

Most Recent Stories

More News
Hoth Therapeutics Announces Sponsored Research Agreement with Washington University for Novel Alzheimer's Therapeutic HT-ALZ

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused  today announced that it has entered into a Sponsored Research Agreement with in to support the continued research and development...

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics Shares Positive Preclinical Results of Novel HT-KIT Therapeutic

, /PRNewswire/ --  (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it will share positive results from a preclinical trial during its shareholder presentation, reinforcing...

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics Plans Shareholder Presentation on HT-KIT Therapeutic's Preclinical Results for Rare Cancers

, /PRNewswire/ --  (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today plans to host a virtual information session on its pipeline product, , a new molecular entity under development...

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics Announces Participation at the American Society of Clinical Oncology (ASCO) Annual Meeting

, /PRNewswire/ -- , Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it will be an exhibitor at the American Society of Clinical Oncology (ASCO) Annual Meeting....

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics Provides Shareholder Update on Novel Endocannabinoid Therapeutic for Cutaneous Lupus Erythematosus

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused  announced today it plans to host a virtual information session on its pipeline product, , a novel endocannibinoid treatment...

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics and Virginia Commonwealth University Expand Research Agreement for COVID-19 Therapeutic

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has expanded its sponsored research agreement with Virginia Commonwealth University (VCU) for...

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics Announces Development of HT-KIT to Treat Multiple Orphan Diseases, Including Rare Cancers

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a patient-focused clinical-stage biopharmaceutical company, announced it intends to pursue development of its HT-KIT mRNA Frame Shifting Therapeutic for...

HOTH : 1.5400 (-4.35%)
Hoth Therapeutics' First in Human Clinical Trial for the Treatment of Atopic Dermatitis with BioLexa is Underway

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs, is pleased to announce the...

HOTH : 1.5400 (-4.35%)
Thinking about buying stock in Hoth Therapeutics, Castor Maritime, Clover Health Investments, Naked Brand, or Virgin Galactic?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HOTH, CTRM, CLOV, NAKD, and SPCE.

CLOV : 12.04 (-4.14%)
CTRM : 2.94 (-4.55%)
HOTH : 1.5400 (-4.35%)
NAKD : 0.6694 (-0.09%)
SPCE : 36.80 (-1.39%)
Hoth Therapeutics Announces its mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell-Derived Cancers

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, announced that its novel  exhibited highly positive results in humanized mast cell...

HOTH : 1.5400 (-4.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is...

See More

Key Turning Points

3rd Resistance Point 1.7500
2nd Resistance Point 1.7000
1st Resistance Point 1.6200
Last Price 1.5400
1st Support Level 1.4900
2nd Support Level 1.4400
3rd Support Level 1.3600

See More

52-Week High 3.8900
Fibonacci 61.8% 2.8877
Fibonacci 50% 2.5782
Fibonacci 38.2% 2.2686
Last Price 1.5400
52-Week Low 1.2663

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar